カレントテラピー 36-6 サンプル

カレントテラピー 36-6 サンプル page 29/34

電子ブックを開く

このページは カレントテラピー 36-6 サンプル の電子ブックに掲載されている29ページの概要です。
秒後に電子ブックの対象ページへ移動します。
「電子ブックを開く」をクリックすると今すぐ対象ページへ移動します。

概要:
カレントテラピー 36-6 サンプル

Current Therapy 2018 Vol.36 No.6 85治療薬解説587enzymes. Dig Dis 28:339-343, 20104)Czako L, Takacs T, Hegyi P, et al:Quality of life assessmentafter pancreatic enzyme replacement therapy in chronic pancreatitis.Can J Gastroenterol 17:597-603, 20035)Brown A, Hughes M, Tenner S, et al:Does pancreaticenzyme supplementation reduce pain in patients with chronicpancreatitis:a meta-analysis. Am J Gastroenterol 92:2032-2035, 19976)Shafiq N, Rana S, Bhasin D, et al:Pancreatic enzymes forchronic pancreatitis. Cochrane Database Syst Rev 7:CD006302, 20097)Slaff J, Jacobson D, Tillman CR, et al:Protease-specific suppressionof pancreatic exocrine secretion. Gastroenterology87:44-52, 19848)Dominguez -Munoz JE, Iglesias -Garcia J:Oral pancreaticenzyme substitution therapy in chronic pancreatitis:is clinicalresponse an appropriate marker for evaluation of therapeuticefficacy? JOP 11:158-162, 20109)Ramo OJ, Puolakkainen PA, Seppala K, et al:Self -administration of enzyme substitution in the treatment ofexocrine pancreatic insufficiency. Scand J Gastroenterol 24:688-692, 198910)American Gastroenterological Association Medical PositionStatement:treatment of pain in chronic pancreatitis.Gastroenterology 115:763-764, 199811)Warshaw AL, Banks PA, Fernandez-Del Castillo C:AGAtechnical review:treatment of pain in chronic pancreatitis.Gastroenterology 115:765-776, 199812)Halgreen H, Pedersen NT, Worning H:Symptomatic effectof pancreatic enzyme therapy in patients with chronic pancreatitis.Scand J Gastroenterol 21:104-108, 198613)Armbrecht U, Svanvik J, Stockbrugger:Enzyme substitutionin chronic pancreatitis:effects on clinical and functionalparameters and on the hydrogen(H2)breath test. Scand JGastroenterol Suppl 126:55-59, 198614)Whitcomb DC, Lehman GA, Vasileva G, et al:Pancrelipasedelayed-release capsules(CREON)for exocrine pancreaticinsufficiency due to chronic pancreatitis or pancreatic surgery:A double-blind randomized trial. Am J Gastroenterol105:2276-2286, 201015)Gubergrits N, Malecka -Panas E, Lehman GA, et al:A6-month, open-label clinical trial of pancrelipase delayedreleasecapsules(Creon)in patients with exocrine pancreaticinsufficiency due to chronic pancreatitis or pancreatic surgery.Aliment Pharmacol Ther 33:1152-1161, 201116)Nakamura T, Takeuchi T, Tando Y:Pancreatic dysfunctionand treatment options. Pancreas 16:329-336, 199817)Marotta F, O’Keefe SJ, Marks IN, et al:Pancreatic enzymereplacement therapy. Importance of gastric acid secretion,H2-antagonists, and enteric coating. Dig Dis Sci 34:456-461,198918)Lankisch PG:Enzyme treatment of exocrine pancreaticinsufficiency in chronic pancreatitis. Digestion 54(Suppl 2):21-29, 199319)Layer P, Keller J, Lankisch PG:Pancreatic enzyme replacementtherapy. Curr Gastroenterol Rep 3:101-108, 200120)Dhanasekaran R, Toskes PP:Pancrelipase for pancreaticdisorders:An update. Drugs Today(Barc)46:855-866,2010